Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
parkinson's disease | Research | Treatment | 10 pages | source: Journal of Parkinson's disease | Added May 08, 2025

Gocovri treatment decreases dyskinesia and off times in patients with Parkinson's disease

This study investigated the effectiveness of Gocovri (amantadine) in the treatment of dyskinesia (DYS) in patients with Parkinson's disease (PD). Researchers suggested that this treatment improves DYS symptoms.

icon
diabetes mellitus | Research | 10 pages | source: Diabetes Research and Clinical Practice | Added May 08, 2025

Alcohol and drug use in young adults with type 1 diabetes

This article examined the prevalence of alcohol and drug use in young adults with type 1 diabetes (T1D). They also investigated the ways these substances can affect the health of young adults with T1D. 

icon
coronary artery disease | Research | 9 pages | source: Atherosclerosis | Added May 07, 2025

Will an intensive statin treatment change composition of plaque?

This paper studied the effect of an early intensive statin treatment in patients who have had a heart attack.

icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: The journal of sexual medicine | Added May 07, 2025

Intralesional therapy and Peyronie's disease

This study looked at different types of intralesional therapy in the treatment of Peyronie's disease (PD). It concluded that different therapies could affect different aspects of PD. 

icon
icon
parkinson's disease | Research | Treatment | 10 pages | source: Journal of Parkinson's disease | Added May 06, 2025

Opicapone is a safe option to treat patients with Parkinson's disease

This study investigated the safety profile of opicapone (Ongentys) in the treatment of Parkinson's disease. Researchers suggested that this drug was safe and well-tolerated in these patients.

icon
diabetes mellitus | Medivizor | source: Medivizor | Added May 06, 2025

Diabetes and Nanotechnology

Before humans are involved in clinical trials, a lot of animal testing occurs.  When something works in animals, there is hope that it will work in people. That’s why the news of nanotechnology applied to diabetes in animals is interesting. Diabetes Research The work is being done through a cooperative effort
icon
icon
erectile dysfunction | Research | Treatment | 10 pages | source: BJU international | Added May 05, 2025

Predicting success for Collagenase clostridium histolyticum treatment in Peyronie's disease

This study looked at the effectiveness of injection of Collagenase Clostridium histolyticum (Xiaflex) (CCh) to treat Peyronie's disease. This study concluded CCh was effective after injection, in the treatment of patients with more severe Peyronie's disease.

icon
coronary artery disease | Research | 10 pages | source: Journal of the American College of Cardiology | Added May 05, 2025

Can lowering blood pressure be a bad thing?

This study examined whether there was a link between low diastolic blood pressure (DBP) and the frequency of angina in patients with coronary artery disease (CAD; heart disease caused by a low blood supply to the heart because of hardened and narrowed blood vessels). The authors concluded that low DBP is associated with an increased risk of angina in these patients.

icon
icon
overactive bladder | Research | Treatment | 10 pages | source: European Urology | Added May 04, 2025

The safety and effectiveness of Mirabegron and Sulifenacin for Overactive Bladder

This study looked at the safety and effectiveness of combination Mirabegron (Myrbetriq) and Solifenacin (Vesicare) treatment in Overactive Bladder (OAB) patients. This study concluded that after 1 year, the combination treatment was safe and more effective than each drug given alone.

icon
diabetes mellitus | Research | 10 pages | source: Diabetes Research and Clinical Practice | Added May 04, 2025

Gestational diabetes increases the risk of metabolic syndrome after pregnancy

The aim of this study was to investigate the risk of metabolic syndrome after pregnancy in women that had gestational diabetes (GD). The main finding of the study was women who had GD had a higher risk of metabolic syndrome after pregnancy.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?